Rt-Medibus Technologies Profile
Key Indicators
- Authorised Capital ₹ 7.50 Cr
as on 17-12-2024
- Paid Up Capital ₹ 5.76 Cr
as on 17-12-2024
- Company Age 15 Year, 7 Months
- Last Filing with ROC 31 Mar 2022
- Revenue 14.11%
(FY 2022)
- Profit 73.08%
(FY 2022)
- Ebitda 88.93%
(FY 2022)
- Net Worth -41.13%
(FY 2022)
- Total Assets -36.13%
(FY 2022)
About Rt-Medibus Technologies
The Corporate was formerly known as Robertson Technologies India Private Limited. The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 7.50 Cr and a paid-up capital of Rs 5.76 Cr, as per Ministry of Corporate Affairs (MCA) records.
Srirama Raja and Kotayamkatankote Nambiar serve as directors at the Company.
- CIN/LLPIN
U85191TN2009PTC115795
- Company No.
115795
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
08 May 2009
- Date of AGM
30 Sep 2022
- Date of Balance Sheet
31 Mar 2022
- Listing Status
Unlisted
- ROC Code
Roc Chennai
Industry
Company Details
- Location
Chennai, Tamil Nadu, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Rt-Medibus Technologies?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Srirama Raja  | Whole-Time Director | 08-May-2009 | Current |
Kotayamkatankote Nambiar  | Whole-Time Director | 08-May-2009 | Current |
Financial Performance and Corporate Structure Insights of Rt-Medibus Technologies.
Rt-Medibus Technologies Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 14.11% increase. The company also saw a substantial improvement in profitability, with a 73.08% increase in profit. The company's net worth observed a substantial decline by a decrease of 41.13%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Rt-Medibus Technologies?
In 2022, Rt-Medibus Technologies had a promoter holding of 17.89% and a public holding of 82.10%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Rt-Medibus Technologies?
Rt-Medibus Technologies has a workforce of 1 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Rt-Medibus Technologies, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Rt-Medibus Technologies's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
